Barrow, Hanley, Mewhinney & Strauss
NUVA

Barrow, Hanley, Mewhinney & Strauss’s NuVasive, Inc. NUVA Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-352
Closed -$21K – 372
2021
Q3 		$21K Buy
+352
New +$21.7K ﹤0.01% 279

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's NUVA Position: Q4 2021 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of NuVasive, Inc. (NUVA) in Q4 2021, closing a stake of 352 shares — an estimated $21K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in NUVA in Q3 2021 and held it in 1 quarter. The position peaked at $21K in Q3 2021. 249 funds tracked by Wall St. Rank hold NUVA as of Q4 2021.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining NuVasive, Inc. position as of Q4 2021 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 352 NuVasive, Inc. shares in Q4 2021, an estimated $21K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in NuVasive, Inc. in Q3 2021 and held it in 1 quarter.
  • Barrow, Hanley, Mewhinney & Strauss's NuVasive, Inc. position peaked at $21K in Q3 2021.
  • 249 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2021.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2021, filed 10 Feb 2022.